首页> 外文期刊>Laryngo- rhino- otologie >Management of T1a vocal fold carcinoma [Management des T1a Stimmlippenkarzinoms]
【24h】

Management of T1a vocal fold carcinoma [Management des T1a Stimmlippenkarzinoms]

机译:T1a声带癌的治疗[T1a声带癌的管理]

获取原文
获取原文并翻译 | 示例
           

摘要

Management of T1a Vocal Fold Carcinoma About 2/3 of the larynxcarcinomas affect the vocal chords. The main risk factor is smoking. Carcinomas in this localisation often arise from leukoplakias with dysplasia. A typical symptom is dysphonia. Arrest of vibration in microlaryngostroboscopy is a hint that a carcinoma could be present. Transoral lasercordectomy or radiotherapy show equivalent oncological results and results in quality of voice in the treatment of vocal fold carcinoma (T1a). As lymph node and distant metastasis are very rare, follow-up can concentrate on microlaryngoscopy. In case of a suspicious area on the vocal fold, biopsy of the affected tissue is needed to plan correct treatment. The prognosis of the T1 vocal chord carcinoma is quite good with a 5-year survival rate of almost 100%.
机译:T1a声带癌的治疗大约2/3的喉癌会影响声带。主要危险因素是吸烟。在这种定位下的癌通常来自具有发育异常的白斑。典型的症状是声音障碍。微喉镜检查中振动的停止提示可能存在癌。经口激光皮层切除术或放射疗法在肿瘤声带癌(T1a)的治疗中显示出相同的肿瘤学结果,并提高了声音质量。由于淋巴结和远处转移非常罕见,因此随访可以集中在微喉镜检查上。如果声带上有可疑区域,则需要对受影响的组织进行活检以计划正确的治疗方法。 T1声带癌的预后相当好,其5年生存率几乎为100%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号